In a recent study, researchers investigated the effects of various trajectories of sleep problems in early and middle childhood on psychosocial and academic outcomes among older children.
The new drug is the first FDA-approved option for this indication in more than 15 years and contains significantly less sodium than a current standard-of-care option.
Members of the Association of Pulmonary, Critical Care, and Sleep Division Directors and the American Thoracic Society have developed guidance for safely resuming elective outpatient pulmonary and sleep...
Previous research has shown that poor sleep quality is associated with worsened asthma symptoms among adolescents. Now, new research reveals the impact of short and long sleep duration on the frequency of...
Can a combination of noradrenergic and antimuscarinic drugs improve the endotypic traits of patients with obstructive sleep apnea? Find out what the authors of a new study determined.
Results of the Harmony III study highlight the long-term benefits of this FDA-approved therapy for narcolepsy. The drug also reduced common comorbidities, including cataplexy.
Studies assessing the prevalence and characteristics of the association between obstructive sleep apnea and poor blood pressure control in patients with resistant hypertension are limited. A new study sheds...
Researchers aimed to understand the global prevalence of obstructive sleep apnea by reviewing current literature and consulting global key opinion leaders.
